Montelukast
Montelukast, a cysteinyl leukotriene receptor antagonist, is being developed for        the treatment of asthma and related diseases.
 @SUBJECT$  @PREDICAT$ , is being developed for        the treatment of  @OBJECT$  and related diseases.